newsfilter
← Latest News
GlobeNewswire·

AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance

IRVINE, Calif., April 25, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. ("AEON" or the "Company") (NYSE:AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the